Literature DB >> 16048359

Tolerability of treatments for postherpetic neuralgia.

Nancy A Alvarez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16048359     DOI： 10.2165/00002018-200528080-00008

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.

Authors:  Arnold R Gammaitoni; Matthew W Davis
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

2.  Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial.

Authors:  F Burch; C Codding; N Patel; E Sheldon
Journal:  Osteoarthritis Cartilage       Date:  2004-03       Impact factor: 6.576

3.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.

Authors:  B S Galer; M C Rowbotham; J Perander; E Friedman
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

4.  Pharmacokinetics and safety of continuously applied lidocaine patches 5%.

Authors:  Arnold R Gammaitoni; Nancy A Alvarez; Bradley S Galer
Journal:  Am J Health Syst Pharm       Date:  2002-11-15       Impact factor: 2.637

Review 5.  Tolerability of treatments for postherpetic neuralgia.

Authors:  Mark W Douglas; Robert W Johnson; Anthony L Cunningham
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.

Authors:  Bradley S Galer; Eric Sheldon; Nileshkumar Patel; Chris Codding; Francis Burch; Arnold R Gammaitoni
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

7.  Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.

Authors:  Michael C Rowbotham; Pamela S Davies; Christina Verkempinck; Bradley S Galer
Journal:  Pain       Date:  1996-04       Impact factor: 6.961

8.  Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.

Authors:  Nathaniel P Katz; Arnold R Gammaitoni; Matthew W Davis; Robert H Dworkin
Journal:  Pain Med       Date:  2002-12       Impact factor: 3.750

9.  Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.

Authors:  William T White; Nileshkumar Patel; Michael Drass; Srinivas Nalamachu
Journal:  Pain Med       Date:  2003-12       Impact factor: 3.750

10.  Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.

Authors:  Torsten Meier; Gunnar Wasner; Markus Faust; Thierry Kuntzer; François Ochsner; Michael Hueppe; Julien Bogousslavsky; Ralf Baron
Journal:  Pain       Date:  2003-11       Impact factor: 6.961
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.